Makers Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 29-06-2024
- Paid Up Capital ₹ 2.90 M
as on 29-06-2024
- Company Age 19 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 8.30 Cr
as on 29-06-2024
- Satisfied Charges ₹ 4.50 Cr
as on 29-06-2024
- Revenue -28.46%
(FY 2021)
- Profit -30.56%
(FY 2021)
- Ebitda -13.02%
(FY 2021)
- Net Worth 9.69%
(FY 2021)
- Total Assets -26.09%
(FY 2021)
About Makers Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.90 M.
The company currently has active open charges totaling ₹8.30 Cr. The company has closed loans amounting to ₹4.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Veena Jain and Mahendra Kumar serve as directors at the Company.
- CIN/LLPIN
U51397TN2005PTC055683
- Company No.
055683
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Mar 2005
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Makers Pharma Private Limited offer?
Makers Pharma Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antifungal Injection, Tablet & Syrup.
Who are the key members and board of directors at Makers Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veena Jain  | Director | 16-Mar-2005 | Current |
| Mahendra Kumar | Director | 16-Mar-2005 | Current |
Financial Performance of Makers Pharma.
Makers Pharma Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 28.46% decrease. The company also saw a substantial fall in profitability, with a 30.56% decrease in profit. The company's net worth moved up by a moderate rise of 9.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Makers Pharma?
In 2021, Makers Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 22 Oct 2012 | ₹7.80 Cr | Open |
Citibank Creation Date: 12 Dec 2005 | ₹5.00 M | Open |
Kotak Mahindra Bank Limited Creation Date: 03 Mar 2007 | ₹4.50 Cr | Satisfied |
How Many Employees Work at Makers Pharma?
Unlock and access historical data on people associated with Makers Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Makers Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Makers Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
